How have GALT and NAUT total returns compared?

Over the past 5 years, GALT delivered 0.60% and NAUT delivered -20.56% annualized total return. Past performance doesn't predict future results.

Galectin Therapeutics Inc. (GALT) vs Nautilus Biotechnolgy, Inc. (NAUT)

A side-by-side comparison of Galectin Therapeutics Inc. and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GALT

Galectin Therapeutics Inc.

$242M

$3.68HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT

NAUT

Nautilus Biotechnolgy, Inc.

$240M

$1.89HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

Total return — GALT vs NAUT

growth of $100 · dividends reinvested · last 6y

GALT +42.9% (+6.1%/yr)NAUT -82.1% (-24.9%/yr)GALT compounded faster over this window

Log scale — wide-divergence pair

GALT NAUT

GALT vs NAUT: by the numbers

•GALT is the larger company ($242M vs $240M market cap).
•Both run net losses; GALT's is the smaller (0.00% vs -29747.89% net margin).

Metrics side by side

Valuation

Metric	GALT	NAUT
P/S ratio	N/A	1264.52
P/B ratio	N/A	1.83

Profitability

Metric	GALT	NAUT
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	-29747.89%
ROE	N/A	-43.11%
ROIC	-1718.59%	-40.52%

Growth (annualized)

Metric	GALT	NAUT
Total return CAGR (5Y)	0.60%	-20.56%

Frequently asked

How have GALT and NAUT total returns compared?: Over the past 5 years, GALT delivered 0.60% and NAUT delivered -20.56% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GALT analysis Full NAUT analysis Interactive comparison tool

Dig into the metrics

Galectin Therapeutics ROE Nautilus Biotechnolgy ROE Galectin Therapeutics operating margin Nautilus Biotechnolgy operating margin Galectin Therapeutics revenue growth Nautilus Biotechnolgy revenue growth Galectin Therapeutics free cash flow Nautilus Biotechnolgy free cash flow

Galectin Therapeutics & Nautilus Biotechnolgy appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.